Worthy Stocks to Watch for: Liberty Global plc – Class C Ordinary Shares (LBTYK), Inovio Pharmaceuticals Inc (INO)


Liberty Global plc – Class C Ordinary Shares (NASDAQ:LBTYK)

Stock’s Trading Stats:

Liberty Global plc – Class C Ordinary Shares (NASDAQ:LBTYK) is trading down with a percentage change of -2.70 % and is at $36.99 right now. The Company’s market capitalization stands at $22.09 Billion in the current trading Session whereas, its outstanding shares are 581.04 Million.

Recent Press Release:

Liberty Global plc – Class C Ordinary Shares (LBTYK) on March 14 announced that the definitive proxy statement (the “Proxy Statement”) in connection with its previously announced proposed acquisition (the “Acquisition”) of all outstanding issued and to be issued shares of Cable & Wireless Communications Plc (“CWC”) (CWC.L) was filed with the SEC today. The mailing of the Proxy Statement to Shareholders of Liberty Global Class A and Class B Ordinary Shares and LiLAC Class A and Class B Ordinary Shares will commence promptly.

The Proxy Statement contains a notice convening the Liberty Global General Meeting of Shareholders on April 20, 2016, to, among other matters, seek the approval of the requisite majorities of the Liberty Global Shareholders for the issuance of ordinary shares of Liberty Global in the Acquisition. The General Meeting of Shareholders will be held at the Four Seasons Hotel Denver, 1111 14th Street, Denver, Colorado 80202 on April 20, 2016, at 10:00 a.m. Mountain Time (5:00 p.m. BST). Only shareholders of record of Liberty Global Class A and Class B Ordinary Shares and LiLAC Class A and Class B Ordinary Shares as of 10:00 p.m. BST (5:00 p.m. Eastern time) on March 10, 2016 may vote at the General Meeting of Shareholders. This event will be webcast and details will be forthcoming.

CWC will soon announce the details regarding the posting of the Scheme Document, the Court Meeting and CWC General Meeting. The completion of the Offer is expected to take place during the middle of May 2016.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

Stock’s Trading Stats:

Inovio Pharmaceuticals Inc (NASDAQ:INO) is declining -3.45% percent and is at $9.33 in the Real-Time trading session. The stock’s market capitalization stands at $703.45 Million with outstanding shares of 72.22 Million.

Recent Press Release:

Inovio Pharmaceuticals, Inc. (INO) on March 30 announced that its Ebola vaccine, INO-4212, was safe, tolerable, and generated strong T cell and antibody responses in its fully enrolled phase I study of 75 healthy subjects. Detailed immunogenicity and safety data is being prepared for peer-reviewed publication. In previously reported preclinical testing in mice and non-human primates, the Ebola vaccine protected 100% of immunized animals from sickness and death following exposure to a lethal dose of Ebola virus.

This human study (CT.gov: NCT02464670) was conducted by an Inovio-led consortium, which was selected and awarded $45 million by the U.S. Defense Advanced Research Projects Agency (DARPA) in 2015 to take a multi-faceted approach to prevent and treat Ebola infection.